Your quote " RAP at a $260m market cap is still good value based on disruptive offering and size of market."
Interesting that a potential market of their (RAPs) size, with a single app, still under clinical trials for a single indication somehow ticks your boxes; but XPE with a Trillion dollar market, in commercial discussions, and half the market cap of RAP, with developed multi-faceted opportunities is a sell in your expert opinion.
Your FA and TA is quite remarkable in my opinion!
purely TA theory posts, page-227
-
- There are more pages in this discussion • 449 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OAK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.862M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 88627 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 2817 | 1 |
View Market Depth
| Last trade - 16.12pm 13/09/2024 (20 minute delay) ? |
| OAK (ASX) Chart |
Day chart unavailable